765959007: Product containing precisely bendroflumethiazide 5 milligram and propranolol hydrochloride 160 milligram/1 each prolonged-release oral capsule (clinical drug)

SNOMED CT Concept\Pharmaceutical / biologic product (product)\Medicinal product (product)\...

\Medicinal product categorized by disposition (product)\Adrenergic receptor antagonist-containing product\Product containing beta adrenergic receptor antagonist (product)\Product containing propranolol (medicinal product)\...

\Product containing bendroflumethiazide and propranolol (medicinal product)\Bendroflumethiazide and propranolol only product\Bendroflumethiazide and propranolol only product in oral dose form\Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule
\Product containing bendroflumethiazide and propranolol (medicinal product)\Bendroflumethiazide- and propranolol-containing product in oral dose form\Bendroflumethiazide and propranolol only product in oral dose form\Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule

\Propranolol-containing product in oral dose form\Bendroflumethiazide- and propranolol-containing product in oral dose form\Bendroflumethiazide and propranolol only product in oral dose form\Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule

\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing propranolol (medicinal product)\Product containing bendroflumethiazide and propranolol (medicinal product)\Bendroflumethiazide and propranolol only product\Bendroflumethiazide and propranolol only product in oral dose form\Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule
\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing propranolol (medicinal product)\Product containing bendroflumethiazide and propranolol (medicinal product)\Bendroflumethiazide- and propranolol-containing product in oral dose form\Bendroflumethiazide and propranolol only product in oral dose form\Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule
\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing propranolol (medicinal product)\Propranolol-containing product in oral dose form\Bendroflumethiazide- and propranolol-containing product in oral dose form\Bendroflumethiazide and propranolol only product in oral dose form\Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule
\Medicinal product categorized by structure\Product containing benzothiadiazine (product)\Product containing bendroflumethiazide (medicinal product)\Bendroflumethiazide-containing product in oral dose form\Bendroflumethiazide- and propranolol-containing product in oral dose form\Bendroflumethiazide and propranolol only product in oral dose form\Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule
\Medicinal product categorized by structure\Product containing benzothiadiazine (product)\Product containing bendroflumethiazide (medicinal product)\Product containing bendroflumethiazide and propranolol (medicinal product)\Bendroflumethiazide and propranolol only product\Bendroflumethiazide and propranolol only product in oral dose form\Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule
\Medicinal product categorized by structure\Product containing benzothiadiazine (product)\Product containing bendroflumethiazide (medicinal product)\Product containing bendroflumethiazide and propranolol (medicinal product)\Bendroflumethiazide- and propranolol-containing product in oral dose form\Bendroflumethiazide and propranolol only product in oral dose form\Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule
\Medicinal product categorized by structure\Product containing alcohol (product)\Product containing propranolol (medicinal product)\Product containing bendroflumethiazide and propranolol (medicinal product)\Bendroflumethiazide and propranolol only product\Bendroflumethiazide and propranolol only product in oral dose form\Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule
\Medicinal product categorized by structure\Product containing alcohol (product)\Product containing propranolol (medicinal product)\Product containing bendroflumethiazide and propranolol (medicinal product)\Bendroflumethiazide- and propranolol-containing product in oral dose form\Bendroflumethiazide and propranolol only product in oral dose form\Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule
\Medicinal product categorized by structure\Product containing alcohol (product)\Product containing propranolol (medicinal product)\Propranolol-containing product in oral dose form\Bendroflumethiazide- and propranolol-containing product in oral dose form\Bendroflumethiazide and propranolol only product in oral dose form\Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule

\Product manufactured as oral dose form (product)\Bendroflumethiazide-containing product in oral dose form\Bendroflumethiazide- and propranolol-containing product in oral dose form\Bendroflumethiazide and propranolol only product in oral dose form\Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule
\Product manufactured as oral dose form (product)\Propranolol-containing product in oral dose form\Bendroflumethiazide- and propranolol-containing product in oral dose form\Bendroflumethiazide and propranolol only product in oral dose form\Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule

\Product containing autonomic agent (product)\Product containing beta adrenergic receptor antagonist (product)\Product containing propranolol (medicinal product)\...

\Product containing bendroflumethiazide and propranolol (medicinal product)\Bendroflumethiazide and propranolol only product\Bendroflumethiazide and propranolol only product in oral dose form\Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule
\Product containing bendroflumethiazide and propranolol (medicinal product)\Bendroflumethiazide- and propranolol-containing product in oral dose form\Bendroflumethiazide and propranolol only product in oral dose form\Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule

\Propranolol-containing product in oral dose form\Bendroflumethiazide- and propranolol-containing product in oral dose form\Bendroflumethiazide and propranolol only product in oral dose form\Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3675107010 Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3675109013 Product containing precisely bendroflumethiazide 5 milligram and propranolol hydrochloride 160 milligram/1 each prolonged-release oral capsule (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule	Has manufactured dose form	Prolonged-release oral capsule	true	Inferred relationship	Some
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule	Is a	Propranolol-containing product in oral dose form	false	Inferred relationship	Some
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule	Is a	Product containing bendroflumethiazide and propranolol (medicinal product)	false	Inferred relationship	Some
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule	This attribute specifies the numerator unit for the presentation strength of a product.	mg	true	Inferred relationship	Some	2
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	Bendroflumethiazide (substance)	false	Inferred relationship	Some	2
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule	This attribute specifies the denominator unit for the presentation strength of a product.	Capsule (unit of presentation)	true	Inferred relationship	Some	2
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	Propranolol hydrochloride	false	Inferred relationship	Some	1
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule	Has presentation strength numerator value	160	false	Inferred relationship	Some	1
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule	Has presentation strength denominator value	un	false	Inferred relationship	Some	1
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	Bendroflumethiazide (substance)	false	Inferred relationship	Some	2
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule	This attribute specifies the numerator unit for the presentation strength of a product.	mg	true	Inferred relationship	Some	1
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule	This attribute specifies the denominator unit for the presentation strength of a product.	Capsule (unit of presentation)	true	Inferred relationship	Some	1
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule	Has presentation strength denominator value	un	false	Inferred relationship	Some	2
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule	Has presentation strength numerator value	cinq	false	Inferred relationship	Some	2
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	Propranolol hydrochloride	false	Inferred relationship	Some	1
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule	Has unit of presentation	Capsule (unit of presentation)	true	Inferred relationship	Some
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule	Is a	Bendroflumethiazide-containing product in oral dose form	false	Inferred relationship	Some
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule	Count of base of active ingredient	deux	false	Inferred relationship	Some
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule	Is a	Bendroflumethiazide and propranolol only product in oral dose form	true	Inferred relationship	Some
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule	Plays role	Diuretic therapeutic role	false	Inferred relationship	Some
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	Bendroflumethiazide (substance)	true	Inferred relationship	Some	1
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	Propranolol hydrochloride	true	Inferred relationship	Some	2
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	Propranolol hydrochloride	true	Inferred relationship	Some	2
Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	Bendroflumethiazide (substance)	true	Inferred relationship	Some	1

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3675107010	Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3675109013	Product containing precisely bendroflumethiazide 5 milligram and propranolol hydrochloride 160 milligram/1 each prolonged-release oral capsule (clinical drug)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core